PGD Human

Phosphogluconate Dehydrogenase Human Recombinant
Cat. No.
BT14117
Source
Escherichia Coli.
Synonyms
EC 1.1.1.44, 6PGD, PGDH, 6-phosphogluconate dehydrogenase decarboxylating, PGD.
Appearance
Sterile Filtered clear colorless solution.
Purity
Greater than 95% as determined by SDS-PAGE.
Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

PGD Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 503 amino acids (1-483 a.a.) and having a molecular mass of 55.3 kDa. The PGD is fused to a 20 amino acid His Tag at N-terminus and purified by proprietary chromatographic techniques.

Product Specs

Introduction
6-phosphogluconate dehydrogenase (6PGD) is the second dehydrogenase in the pentose phosphate pathway. The pentose phosphate pathway is essential for nucleic acid biosynthesis and a major source of NADPH. 6PGD deficiency is typically asymptomatic and is inherited in an autosomal dominant manner. This deficiency can elevate erythrocyte pyruvate kinase activity and decrease glutathione synthetase, potentially leading to hemolysis.
Description
Recombinant human 6PGD, expressed in E. coli, is a non-glycosylated polypeptide chain containing 503 amino acids (with amino acids 1-483 present) and having a molecular mass of 55.3 kDa. The protein includes a 20 amino acid His-tag at the N-terminus and is purified using proprietary chromatographic techniques.
Physical Appearance
Clear, colorless, and sterile-filtered solution.
Formulation
The PGD solution is formulated in 20mM Tris-HCl (pH 8), 1mM DTT, 0.1M NaCl, and 10% glycerol.
Stability
For short-term storage (up to 2-4 weeks), store at 4°C. For extended storage, freeze at -20°C. Adding a carrier protein (0.1% HSA or BSA) is recommended for long-term storage. Minimize repeated freeze-thaw cycles.
Purity
Purity is greater than 95% as determined by SDS-PAGE.
Synonyms
EC 1.1.1.44, 6PGD, PGDH, 6-phosphogluconate dehydrogenase decarboxylating, PGD.
Source
Escherichia Coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MAQADIALIG LAVMGQNLIL NMNDHGFVVC AFNRTVSKVD DFLANEAKGT KVVGAQSLKE MVSKLKKPRR IILLVKAGQA VDDFIEKLVP LLDTGDIIID GGNSEYRDTT RRCRDLKAKG ILFVGSGVSG GEEGARYGPS LMPGGNKEAW PHIKTIFQGI AAKVGTGEPC CDWVGDEGAG HFVKMVHNGI EYGDMQLICE AYHLMKDVLG MAQDEMAQAF EDWNKTELDS FLIEITANIL KFQDTDGKHL LPKIRDSAGQ KGTGKWTAIS ALEYGVPVTL IGEAVFARCL SSLKDERIQA SKKLKGPQKF QFDGDKKSFL EDIRKALYAS KIISYAQGFM LLRQAATEFG WTLNYGGIAL MWRGGCIIRS VFLGKIKDAF DRNPELQNLL LDDFFKSAVE NCQDSWRRAV STGVQAGIPM PCFTTALSFY DGYRHEMLPA SLIQAQRDYF GAHTYELLAK PGQFIHTNWT GHGGTVSSSS YNA.

Product Science Overview

Structure and Function

PGD is a protein-coding gene, and the human recombinant form is typically produced in E. coli for research and therapeutic purposes . The enzyme’s activity is essential for cellular processes that require NADPH, such as fatty acid synthesis and the maintenance of reduced glutathione levels, which protect cells from oxidative damage .

Genetic and Biochemical Characteristics

The PGD gene is located on chromosome 1 and has several transcript variants encoding different isoforms . The enzyme’s deficiency is generally asymptomatic, but combined deficiency with 6-phosphogluconolactonase can lead to hemolysis, suggesting a synergistic effect of these enzymopathies .

Recombinant Production

Recombinant human PGD is produced using E. coli expression systems. The recombinant protein is often tagged with a His-tag for purification purposes and is supplied in a carrier-free form to avoid interference in experimental applications . The enzyme’s activity is measured by its ability to dehydrogenate 6-phosphogluconic acid, with a specific activity greater than 6000 pmol/min/μg .

Applications in Research

Recombinant PGD is widely used in biochemical and physiological studies to understand its role in the PPP and its impact on cellular metabolism. It is also used in drug development and therapeutic research, particularly in studies related to oxidative stress and metabolic disorders .

Clinical Relevance

While PGD deficiency is typically asymptomatic, it can be associated with certain conditions such as cutaneous leishmaniasis and 6-phosphogluconolactonase deficiency . Understanding the enzyme’s function and regulation can provide insights into these conditions and potential therapeutic approaches.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.